A carregar...
Tumor-Agnostic Drug Development
Therapies designed to target cancers that harbor specific molecular signatures have reshaped the landscape of oncologic drug development, and advances in next generation sequencing have led to an increase in the identification of these alterations across tumor types. Tumor-agnostic trial designs, su...
Na minha lista:
| Publicado no: | Am Soc Clin Oncol Educ Book |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7506519/ https://ncbi.nlm.nih.gov/pubmed/30231313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_200831 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|